Aims Inhibition of nitric oxide synthesis causes a decrease in the basal diameter of normal distal epicardal coronary arteries in normal subjects. The effects of inhibition of nitric oxide in atheromatous coronary arteries is unknown. This study assessed the effects of the inhibition of nitric oxide synthesis in epicardial coronary arteries in patients with coronary artery disease.
Introduction
The endothelium influences vascular tone by the release of various relaxing and constricting factors which modulate the contractile activity of the underlying smooth muscle' 1 " 31 . Endothelium-derived relaxing factor is one of the mediators of vascular smooth muscle relaxation' 4 " 81 . Nitric oxide, synthesized by endothelial cells from L-arginine, has been identified as one endotheliumderived relaxing factor although-there may be others' 9 " 131 . The synthesis of nitric oxide can be specifically and competitively antagonized by arginine analogues such as N G -monomethyl-L-arginine ( L N M M A ) , which inhibit the enzymatic pathway in a process that can be reversed by increased availability of L-arginine' Correspondence. Dimitris Tousoulis MD, Cardiology Unit, Hammersmith Hospital, Du Cane Road, London W12 0NN, U.K. causes a decrease in the basal diameter of the distal segments of angiographically normal epicardial coronary arteries in patients' 171 . It is also associated with expression of P-selectin, which results in the triggering of inflammation by stimulating chemotaxis of neutrophils and other inflammatory cells' 181 . The effects of inhibition of nitric oxide in atheromatous coronary arteries is unknown.
We have investigated the effects of an intracoronary infusion of L N M M A on epicardial coronary artery luminal diameter in patients with chronic stable angina due to coronary artery disease.
Methods

Patients
Thirteen patients (11 male, two female, mean age 57 ± 7 years) with chronic stable angina, coronary artery disease and a positive treadmill exercise test result (>0-l mV ST segment depression) at between 5 and 7 metabolic equivalents using the modified Bruce protocol, were studied. Patients were excluded from the study 0195-668X/97/040608 + 06 S18.00/0if they had diabetes mellitus, recent myocardial infarction (<6 months), left ventricular hypertrophy (on echocardiography), left ventricular dysfunction (left ventricular ejection fraction <50%) or valvular heart disease. Antianginal medication was stopped 24 h before the study. The patients were allowed to use sublingual nitroglycerin as necessary, but no study was performed within 3 h of its administration. The protocol was approved by the Research Ethics Committee and each patient gave written informed consent.
Protocol
Following the diagnostic coronary angiogram, an optimal radiographic projection was selected and kept constant for subsequent angiograms. The artery studied was chosen to comply with the Research Ethics Committee's requirements that coronary stenoses causing approximately >75% luminal diameter reduction be avoided. Seventeen stenoses with luminal diameter reduction 20-2% to 70-0% were examined.
Protocol 1
Two ECG leads were monitored continuously throughout the study. During a preliminary study in two patients we infused very low doses of L N M M A (Clinalfa) into the coronary arteries (1 umol. min~ ', 2 umol. min~ ', 4 umol. min~ ') for 4 min. There were no adverse effects, but in one of these patients constriction of the distal coronary artery and increased blood pressure was observed at the 4 umol. min ~ ' dose. Nine patients received a single 2 min infusion of 0-9% saline (2 ml. min" ') followed by a 4 min infusion of L N M M A (4 umol in 2 ml. min~ ') in saline, using a syringe pump, followed by an intracoronary bolus dose of nitroglycerin (250 ug in 2 ml of saline).
Protocol 2
Two ECG leads were monitored continuously throughout the study. Four patients received a single 2 min infusion of 09% saline (2 ml. min " ' ) followed by a 4 min infusion of incremental doses of L N M M A (2, 4, 8, 16 umol . min" 1 ) in saline, using a syringe pump, followed by an intracoronary bolus dose of nitroglycerin (250 ng in 2 ml of saline).
Femoral arterial pressure and heart rate were recorded during the last 30 s of each infusion period. Angiography was performed with a hand injection of 6-8 ml non-ionic contrast medium at baseline, immediately after each infusion and 2-3 min after nitroglycerin. Before each angiogram, the catheter was emptied to avoid bolus administration of the infusate.
Quantitative coronary angiography
The arterial segments in each frame were analysed in random order using quantitative computerized analysis with an automated edge contour detection analysis system (Computerized Angiographic Analysis System [CAAS], Version 2V2; Pie Data Medical) 1191 . Enddiastolic frames from each arteriogram were selected for analysis. The angiographic catheter was used as a scaling device and this, together with the pincushion-distortion correction, allowed the diameters to be recorded as absolute values (expressed in mm). Recorded variables at baseline and after saline, L N M M A , and nitrate administration were: (1) the luminal diameter of angiographically normal proximal and distal segments: the proximal left anterior descending coronary artery diameter was measured just beyond the origin of the artery, and the distal diameter was measured just distal to the second diagonal branch; the proximal left circumflex coronary artery diameter was measured just beyond the origin of the artery, and the distal diameter just beyond the origin of the second obtuse marginal branch; the proximal right coronary artery diameter was measured just beyond the origin of the artery, and the distal diameter just beyond the posterior descending branch; (2) the minimum luminal diameter at the site of coronary stenosis.
Quantitative analysis of coronary arteriograms was carried out by two independent observers, who blindly reanalysed the films at a remote time for reproducibility of the method. No significant intra-or interobserver variability was found (analysis of variance F = 0-35, />=0-80).
Statistical analysis
Data are expressed as mean ± standard error of the mean (SEM). When serial changes in the heart rate, blood pressure and arterial diameter were compared within the group and between the groups, analysis of variance for repeated measures was used. Student's t-test was used to compare paired or unpaired data. Discrete data were analysed by the •/} test. P values of <0-05 (two tailed) were considered significance.
to indicate statistical
Results
Six patients had hypercholesterolaemia (serum cholesterol level >220mg . dl~'), seven were hypertensives and six were smokers.
LNMMA infusion 4 \imol. min ' (protocol 1)
The heart rate remained unchanged during L N M M A infusion (72 ± 1 -3 and 74 ± 1-7 beats. min " ' at baseline and after L N M M A respectively), but there was a significant change in systolic blood pressure (134 ±6-3 and 140 ± 60 mmHg at baseline and after L N M M A respectively, / > <001), and one patient developed chest pain.
The response to L N M M A varied markedly between individual patients (Fig. 1) . There was no significant change in the luminal diameter of proximal segments or at the site of stenosis, but there was a significant reduction in the luminal diameter of distal segments (Table 1) . A greater proportion of distal segments than of proximal segments snowed a reduction in luminal diameter of more than 10% in response to L N M M A and an increase of greater than 10% in response to nitrates (Table 2) .
LNMMA infusion 2 to 16 \imol. min ' (protocol 2)
During the highest L N M M A concentration, the heart rate remained unchanged (66 ± 2-8 at baseline and 69 ± 2-5 beats. min~' after L N M M A ) , but there was a significant change in systolic blood pressure (145 ± 15 at baseline and 156 ± 13 mmHg after L N M M A , /><005), and one patient developed chest pain.
There was no significant change in luminal diameter in the proximal segments (Table 3 ). However, there was a significant reduction in the luminal diameter of distal segments at L N M M A concentrations of 4, 8 and 16 umol. min ~' (Table 3 , Fig. 2) , and a greater proportion of distal segments than of proximal segments showed a reduction in luminal diameter of more than 10% (Table 2) . At 16 umol. min" 1 , the magnitude of vasoconstriction was greater in distal than in proximal segments (P<0-05), and the coronary stenoses showed significant constriction (/ > <001) ( Table 3 , Fig. 2 ).
Discussion
In this study we examined the effects of L N M M A in patients with coronary artery disease and stable angina. The LNMMA-induced constriction and nitrate-induced dilatation were greater in distal than in proximal segments and there was greater variation in response between individuals, particularly at 4 umol. min~'. The proximal segments showed no significant constriction at any L N M M A concentration, but dilated in response to nitrate. The stenoses showed significant constriction only at the highest infused concentration of L N M M A (16 umol. min~ '). Differential reactivity between proximal and distal segments, particularly when expressed as percentage change, has been found in response to many vasoactive stimuli and appears to be an inherent characteristic of human coronary arteries which is not disease dependent. This differential activity could reflect a difference in the ratio of the endothelial cells to smooth muscle cells. Constriction in the distal vessels presumably indicates that there is basal production of nitric oxide and therefore that the endothelium in those vessels is synthesizing nitric oxide in spite of proximal disease. The lack of response to inhibition of nitric oxide synthesis in the proximal segments of patients with coronary artery disease may have been a reflection of proximal endothelial damage related to subtle non-angiographically detectable lesions. The fact that proximal segments and stenoses responded to nitroglycerin, even when there was little or no response to inhibition of nitric oxide synthesis, suggests that these segments maintained the physical ability to contract. It is therefore likely that the lack of response to L N M M A is due to the loss of the site or mechanism of nitric oxide synthesis. Although at lower concentrations the response of stenoses was similar to that of proximal segments (in which they were mostly located), at 16 umol. min" 1 constriction occurred. This raises the possibility that basal nitric oxide production is preserved at the site of stenosis. Preserved local nitric oxide production is likely to originate from the endothelial cells of the vasa vasorum which is more abundant around atherosclerotic plaque' 201 . In a recent study [l7] Lefroy et al. examined the effects of L N M M A in the human circulation and on the coronary vascular responses to acetylcholine and sodium nitroprusside in patients with normal coronary arteries. They showed that the inhibition of nitric oxide synthesis in human coronary circulation caused a decrease in basal distal coronary artery diameter and basal coronary blood flow, indicating that there is a small basal release of nitric oxide in the distal epicardial coronary arteries and resistive vessels. Furthermore, they showed that distal epicardial coronary artery dilation in response to acetylcholine is nitric-oxide dependent, but coronary resistive vessel dilation is not. Chu et a/.'
16211
, in an experimental model, showed that after systemic doses of L N M M A sufficient to raise the blood pressure and decrease the heart rate, there was a reduction in proximal epicardial coronary artery diameter of between 5-5% and 8%. In previous studies, indirect evidence for the role of nitric oxide production in the human coronary circulation has been obtained with agents such as acetylcholine, substance P, and serotonin, which are known to stimulate endothelial nitric oxide production' 22 " 251 .
These studies have shown that intracoronary infusion of each of these agents causes dilation of normal coronary arteries and that the effect at a given dose is more marked in the distal than in the proximal segments. These findings, together with our data, Table 3 Reactivity of proximal and distal segments and coronary stenoses to intracoronary LNMMA (16 ) The results of our study indicate a dosedependent effect of basal nitric oxide production on the tone of epicardial coronary arteries in humans in the resting state. The concentration of L N M M A used in our present study was sufficient to increase systemic arterial pressure and therefore certainly had an inhibitory effect on nitric oxide synthase. Although there is a basal production of nitric oxide by diseased coronary arteries, under conditions which stimulate endothelial nitric oxide production, the response to stimulation could be sufficiently impaired to prevent an adequate fall in coronary vascular resistance, with concomitant limitation of coronary flow increase and consequent myocardial ischaemia' 2627 '.
Since an inhibitor of nitric oxide synthesis had not previously been infused in patients with coronary artery disease, we elected initially to infuse very low doses of L N M M A into the coronary arteries of the first two patients. We did not infuse doses higher than 16 umol. min~', because the increase in blood pressure observed in these patients indicated that a sufficient dose of L N M M A had been delivered to the coronary circulation. In our study we found that coronary stenoses constricted only at the highest L N M M A concentration. This is consistent with low basal production of nitric oxide by endothelium which has been damaged by the atherosclerotic process, and the lower inherent reactivity of proximal segments in which the stenoses were located.
In conclusion, in patients with chronic stable angina, coronary artery disease changes the response of proximal segments to inhibition of nitric synthesis, but not the response of distal segments. The change in response is compatible with disease induced changes in endothelium and endothelial function.
